Modification of the Cardiovascular Effects of L -Dopa in Anesthetized Dogs by Inhibitors of Enzymes Involved in Catecholamine Metabolism
- 1 June 1971
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 28 (6), 662-670
- https://doi.org/10.1161/01.res.28.6.662
Abstract
The influence of various enzyme inhibitors on the cardiovascular effects of L-dopa (methylester) has been studied to determine the sites of action of the drug or a responsible metabolite. L-Dopa, 10 mg/kg, iv, had minor early effects on heart rate and blood pressure in normal dogs, but in animals with inhibition of monoamine oxidase (MAO), it caused tachycardia and severe hypotension of gradual onset. When MAO was inhibited, earlier doses of a dopamine β-oxidase inhibitor (FLA 63) did not significantly modify the effects of L-dopa; prior administration of a decarboxylase inhibitor, NSD 1055 or Ro 4-4602, prevented all but the initial effects; selective extracerebral decarboxylase inhibition with MK 486 (L-α-hydrazino-α-methyldopa) prevented the tachycardia but not the hypotension. DL-threo-Dihydroxyphenylserine caused an initial rise in blood pressure in dogs with MAO inhibition, had less pressor activity when peripheral decarboxylase was also inhibited, and in both cases did not cause the hypotension characteristic of L-dopa. L-Dopa enhanced pressor responses and especially associated bradycardic responses to norepinephrine in dogs with MAO inhibition. This action was prevented by all decarboxylase inhibitors but not FLA 63. Responses to angiotensin were similarly augmented. Thus, MAO inhibition enabled L-dopa to induce severe hypotension, which appeared to rely on a central conversion to dopamine; the other effects were probably mediated by peripherally formed dopamine.Keywords
This publication has 15 references indexed in Scilit:
- Mechanism of the hypotensive action of methyldopa in normal and immunosympathectomized ratsBritish Journal of Pharmacology, 1970
- Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the ratJournal of Pharmacy and Pharmacology, 1970
- Hypotension Caused by L-DopaBMJ, 1970
- Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylaseJournal of Pharmacy and Pharmacology, 1969
- The combined use of α-methyltyrosine and threo-dihydroxyphenylserine—selective reduction of dopamine levels in the central nervous systemBiochemical Pharmacology, 1968
- Diminished effects of sympathetic nerve stimulation in cats pretreated with disulfiram; liberation of dopamine as sympathetic transmitterLife Sciences, 1965
- Impairment of sympathetic nerve responses by dopa, dopamine and their α-methyl analoguesJournal of Pharmacy and Pharmacology, 1965
- Inhibition of dopa decarboxylase by the hydrazino analog of α-methyldopaBiochemical Pharmacology, 1962
- Inhibition of norepinephrine synthesis in mouse brain by blockade of dopamine-β-oxidaseLife Sciences, 1962
- BIOCHEMICAL AND PHARMACOLOGICAL STUDIES OF β‐PHENYLETHYLHYDRAZINE AND SELECTED RELATED COMPOUNDSAnnals of the New York Academy of Sciences, 1959